The Biden administration said Friday it has reached an agreement with Moderna to buy 66 million doses of the company's next generation of COVID-19 vaccine that targets the highly transmissible omicron variant, enough supply ...
Jul 29, 2022
0
3
The "spectacular" success of mRNA (messenger ribonucleic acid) vaccine technology against SARS-CoV-2 provides "just a glimpse of their full potential", according to the authors of a Perspective published by the Medical Journal ...
Jul 5, 2022
0
4
Nearly a year after many rich nations achieved widespread vaccination against COVID-19, many less affluent countries still face difficult choices about which groups of people should be the first to receive vaccines from a ...
Jun 15, 2022
0
13
The vast potential of non-viral delivery systems of mRNA and pDNA has been demonstrated in the vaccines against coronavirus disease 2019 (COVID-19). Indeed, two formulations of mRNA vaccines from Pfizer–BioNTech and Moderna ...
Apr 15, 2022
0
16
Imagine a COVID-19 vaccine that came as a pill: no needles, no medical professionals required to administer it, potentially delivered directly to people's homes.
Aug 1, 2021
0
121
Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences developed deformable albumin-stabilized emulsions that could improve lymph node delivery efficiency and immune response effect, ...
Jul 22, 2021
0
1
Strategic vaccine delivery is critical to reducing COVID-19 transmission, mortality and long-term health impacts. A study published in PLOS Computational Biology by Sam Moore, Matt Keeling and colleagues at University of ...
May 6, 2021
0
0
The current COVID-19 vaccination campaign involves injecting the vaccine into muscle tissue, but injecting a smaller amount of vaccine in the skin might also provide good protection. The #wakeuptocorona crowdfunding campaign ...
Apr 14, 2021
0
2
Pfizer and BioNTech said Saturday they will limit the delays of their vaccine deliveries to just one week, after fears in Europe that shipments of the jabs could be slowed for up to a month.
Jan 16, 2021
0
8
U.S. pharmaceutical company Pfizer confirmed Friday it will temporarily reduce deliveries to Europe of its COVID-19 vaccine while it upgrades production capacity to 2 billion doses per year.
Jan 15, 2021
0
2
